Bionano Genomics Inc (NASDAQ: BNGO) open the trading on Thursday, with a bit cautious approach as it glided -8.12% to $1.47, before settling in for the price of $1.6 at the close. Taking a more long-term approach, BNGO posted a 52-week range of $1.50-$22.80.
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 40.63%. Meanwhile, its Annual Earning per share during the time was 40.63%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 91.90%. This publicly-traded company’s shares outstanding now amounts to $9.76 million, simultaneously with a float of $8.06 million. The organization now has a market capitalization sitting at $14.34 million. At the time of writing, stock’s 50-day Moving Average stood at $2.1317, while the 200-day Moving Average is $3.3868.
Bionano Genomics Inc (BNGO) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Medical Instruments & Supplies industry. Bionano Genomics Inc’s current insider ownership accounts for 17.54%, in contrast to 9.97% institutional ownership.
Bionano Genomics Inc (BNGO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.75 per share during the current fiscal year. Bionano Genomics Inc’s EPS increase for this current 12-month fiscal period is 91.90% and is forecasted to reach -3.60 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 75.99% through the next 5 years, which can be compared against the 40.63% growth it accomplished over the previous five years trading on the market.
Bionano Genomics Inc (NASDAQ: BNGO) Trading Performance Indicators
Let’s observe the current performance indicators for Bionano Genomics Inc (BNGO). It’s Quick Ratio in the last reported quarter now stands at 1.41. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.52.
In the same vein, BNGO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -44.85, a figure that is expected to reach -1.79 in the next quarter, and analysts are predicting that it will be -3.60 at the market close of one year from today.
Technical Analysis of Bionano Genomics Inc (BNGO)
[Bionano Genomics Inc, BNGO] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 18.39% While, its Average True Range was 17.07.
Raw Stochastic average of Bionano Genomics Inc (BNGO) in the period of the previous 100 days is set at 0.12%, which indicates a major fall in contrast to 0.99% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0869 that was lower than 0.1834 volatility it exhibited in the past 100-days period.
